Europe Bioproduction Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Bioproduction Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Bioproduction Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Adoption of Regenerative Medicines
5.1.2 Increasing Prevalence of Chronic Diseases

5.2 Market Opportunities

5.2.1 Patent Expiry of Blockbuster Biologics

5.3 Future Trends

5.3.1 Shift Toward Automated Cell Therapy Manufacturing

5.4 Impact of Drivers and Restraints

6. Europe Bioproduction Market Regional Analysis

6.1 Europe Bioproduction Market Overview

6.2 Europe Bioproduction Market Revenue 2020-2030 (US$ Million)

6.3 Europe Bioproduction Market Forecast Analysis

7. Europe Bioproduction Market Analysis – by Product

7.1 Biologics and Biosimilars

7.1.1 Overview
7.1.2 Biologics and Biosimilars: Europe Bioproduction Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Vaccines

7.2.1 Overview
7.2.2 Vaccines: Europe Bioproduction Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Cell and Gene Therapies

7.3.1 Overview
7.3.2 Cell and Gene Therapies: Europe Bioproduction Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Nucleic Acid Therapeutics

7.4.1 Overview
7.4.2 Nucleic Acid Therapeutics: Europe Bioproduction Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Bioproduction Market Analysis – by Application

8.1 Rheumatoid Arthritis

8.1.1 Overview
8.1.2 Rheumatoid Arthritis: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Hematological Disorders

8.2.1 Overview
8.2.2 Hematological Disorders: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Cancer

8.3.1 Overview
8.3.2 Cancer: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Diabetes

8.4.1 Overview
8.4.2 Diabetes: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Cardiovascular Diseases

8.5.1 Overview
8.5.2 Cardiovascular Diseases: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Bioproduction Market Analysis – by Equipment

9.1 Upstream Equipment

9.1.1 Overview
9.1.2 Cardiovascular Diseases: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Downstream Equipment

9.2.1 Overview
9.2.2 Cardiovascular Diseases: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Bioreactors

9.3.1 Overview
9.3.2 Cardiovascular Diseases: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

9.4 Consumables and Accessories

9.4.1 Overview
9.4.2 Cardiovascular Diseases: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Bioproduction Market – Europe Analysis

10.1 Europe

10.1.1 Europe Bioproduction Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Europe Bioproduction Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 UK: Europe Bioproduction Market Breakdown, by Product
10.1.1.1.2 UK: Europe Bioproduction Market Breakdown, by Application
10.1.1.1.3 UK: Europe Bioproduction Market Breakdown, by Equipment

10.1.1.2 Germany: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Germany: Europe Bioproduction Market Breakdown, by Product
10.1.1.2.2 Germany: Europe Bioproduction Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Bioproduction Market Breakdown, by Equipment

10.1.1.3 France: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 France: Europe Bioproduction Market Breakdown, by Product
10.1.1.3.2 France: Europe Bioproduction Market Breakdown, by Application
10.1.1.3.3 France: Europe Bioproduction Market Breakdown, by Equipment

10.1.1.4 Russia: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Russia: Europe Bioproduction Market Breakdown, by Product
10.1.1.4.2 Russia: Europe Bioproduction Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Bioproduction Market Breakdown, by Equipment

10.1.1.5 Italy: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Italy: Europe Bioproduction Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Bioproduction Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Bioproduction Market Breakdown, by Equipment

10.1.1.6 Rest of Europe: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Bioproduction Market Breakdown, by Product
10.1.1.6.2 Rest of Europe: Europe Bioproduction Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Bioproduction Market Breakdown, by Equipment

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Bioproduction Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 bbi-biotech GmbH

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bio-Rad Laboratories Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Danaher Corp

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 F. Hoffmann-La Roche Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 FUJIFILM Irvine Scientific Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Lonza Group AG

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Merck KGaA

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Sartorius AG

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Thermo Fisher Scientific Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights